Section VI
(38 k) (33 k) (55 k) (40 k) (39 k) (29 k) (29 k) (31 k) (29 k) (30 k) (30 k) (31 k) (31 k) (33 k) (30 k) (66 k) (30 k) (22 k) (37 k) (22 k) (30 k) (22 k) (37 k) (22 k) (37 k) (54 k) | View HTML | View PDF | |
|---|---|---|
Section VI | ||
| 6.1a | Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1997 to 2006 | (38 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 6.1b | Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active and Inactive Patient Comparison, 2002 to 2006 | (33 k) |
| Age | ||
| Gender | ||
| Race | ||
| Time on Waiting List | ||
| 6.2 | Time to Transplant, 1997 to 2006 New Pancreas Transplant Alone (PTA) Waiting List Registrations | (55 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| 6.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Pancreas Transplant Alone (PTA) Waiting List | (40 k) |
| Age | ||
| Blood Type | ||
| Gender | ||
| Race | ||
| 6.4 | Transplant Recipient Characteristics, 1997 to 2006 Pancreas Transplant Alone (PTA) Recipients | (39 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| 6.5 | Incidence of Transplant, 1997 to 2006 Pancreas Transplant Alone (PTA) Transplants per 1 Million Population | (29 k) |
| 6.6a | Immunosuppression Use for Induction, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants | (29 k) |
| 6.6b | Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants | (31 k) |
| 6.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants | (29 k) |
| 6.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants | (30 k) |
| 6.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants | (30 k) |
| 6.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants | (31 k) |
| 6.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants | (31 k) |
| 6.6h | Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants | (33 k) |
| 6.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants | (30 k) |
| 6.7 | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) Transplantation | (66 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| Previous Transplant Any Organ | ||
| 6.8 | Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (30 k) |
| Age | ||
| Gender | ||
| Race | ||
| 6.9 | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.10 | Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (37 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| 6.11 | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.12 | Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (30 k) |
| Age | ||
| Gender | ||
| Race | ||
| 6.13 | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.14 | Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (37 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Cold Ischemic Time | ||
| Hospitalized at Tx | ||
| Level of HLA Mismatch | ||
| 6.15 | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants | (22 k) |
| 6.16 | Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1997 to 2005 | (37 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| 6.17 | Transplants by State and Transplant Center, 1997 to 2006 Pancreas Transplant Alone (PTA) | (54 k) |